참고문헌
- Kang SJ, Mintz GS, Park DW, et al. Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis. Circ Cardiovasc Interv 2011;4:9-14. https://doi.org/10.1161/CIRCINTERVENTIONS.110.940320
- Cho YK, Hur SH. Practical application of coronary imaging devices in cardiovascular intervention. Korean Circ J 2015;45:87-95. https://doi.org/10.4070/kcj.2015.45.2.87
- Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52. https://doi.org/10.1161/01.CIR.99.1.44
- Nakano M, Virmani R. Histopathology of vascular response to drug-eluting stents: an insight from human autopsy into daily practice. Cardiovasc Interv Ther 2015;30:1-11. https://doi.org/10.1007/s12928-014-0281-5
- Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202. https://doi.org/10.1016/j.jacc.2006.03.042
- Otsuka F, Vorpahl M, Nakano M, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation 2014;129:211-23. https://doi.org/10.1161/CIRCULATIONAHA.113.001790
- Simon C, Palmaz JC, Sprague EA. Influence of topography on endothelialization of stents: clues for new designs. J Long Term Eff Med Implants 2000;10:143-51.
- Kolandaivelu K, Swaminathan R, Gibson WJ, et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 2011;123:1400-9. https://doi.org/10.1161/CIRCULATIONAHA.110.003210
- Joner M, Nakazawa G, Finn AV, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008;52:333-42. https://doi.org/10.1016/j.jacc.2008.04.030
- Gonzalo N, Serruys PW, Okamura T, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009;158:284-93. https://doi.org/10.1016/j.ahj.2009.06.004
- Nakano M, Vorpahl M, Otsuka F, et al. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging 2012;5:71-82. https://doi.org/10.1016/j.jcmg.2011.09.015
- Lutter C, Mori H, Yahagi K, et al. Histopathological differential diagnosis of optical coherence tomographic image interpretation after stenting. JACC Cardiovasc Interv 2016;9:2511-23. https://doi.org/10.1016/j.jcin.2016.09.016
- Lee SY, Shin DH, Kim JS, et al. Optical coherence tomographic observation of morphological features of neointimal tissue after drug-eluting stent implantation. Yonsei Med J 2014;55:944-52. https://doi.org/10.3349/ymj.2014.55.4.944
- Lee SY, Hong MK, Mintz GS, et al. Temporal course of neointimal hyperplasia following drug-eluting stent implantation: a serial follow-up optical coherence tomography analysis. Int J Cardiovasc Imaging 2014;30:1003-11. https://doi.org/10.1007/s10554-014-0437-5
- Habara M, Terashima M, Nasu K, et al. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study. Eur Heart J Cardiovasc Imaging 2013;14:276-84. https://doi.org/10.1093/ehjci/jes183
- Fukuhara K, Okura H, Kume T, Yamada R, Neishi Y, Uemura S. In-stent neointimal characteristics and late neointimal response after drug-eluting stent implantation: a preliminary observation. J Cardiol 2016;67:437-41. https://doi.org/10.1016/j.jjcc.2015.07.002
- Kimura T, Yokoi H, Nakagawa Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 1996;334:561-6. https://doi.org/10.1056/NEJM199602293340903
- Kim JS, Lee JH, Shin DH, et al. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation. JACC Cardiovasc Imaging 2014;7:788-95.
- Lee SY, Hong MK, Shin DH, et al. Mechanisms of postintervention and 9-month luminal enlargement after treatment of drug-eluting in-stent restenosis with a drug-eluting balloon. Am J Cardiol 2014;113:1468-73. https://doi.org/10.1016/j.amjcard.2014.01.424
- Itoh T, Fusazaki T, Kimura T, et al. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography. Coron Artery Dis 2015;26:201-11. https://doi.org/10.1097/MCA.0000000000000225
- Otsuka F, Byrne RA, Yahagi K, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J 2015;36:2147-59. https://doi.org/10.1093/eurheartj/ehv205
- Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011;57:1314-22. https://doi.org/10.1016/j.jacc.2011.01.011
- Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012;59:1058-72. https://doi.org/10.1016/j.jacc.2011.09.079
- Imanaka T, Fujii K, Hao H, et al. Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: optical coherence tomography and histopathology validation study. Int J Cardiol 2016;221:1043-7. https://doi.org/10.1016/j.ijcard.2016.07.110
- Souteyrand G, Amabile N, Mangin L, et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J 2016;37:1208-16. https://doi.org/10.1093/eurheartj/ehv711
- Taniwaki M, Radu MD, Zaugg S, et al. Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation 2016;133:650-60. https://doi.org/10.1161/CIRCULATIONAHA.115.019071
- Lee SY, Ahn JM, Mintz GS, et al. Characteristics of earlier versus delayed presentation of very late drug-eluting stent thrombosis: an optical coherence tomographic study. J Am Heart Assoc 2017;6:e005386.
- Lee SY, Shin DH, Mintz GS, et al. Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis. EuroIntervention 2013;9:945-51. https://doi.org/10.4244/EIJV9I8A158
- Kim JS, Hong MK, Shin DH, et al. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT. JACC Cardiovasc Imaging 2012;5:1147-55. https://doi.org/10.1016/j.jcmg.2012.01.024
- Kimura T, Abe K, Shizuta S, et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 2002;105:2986-91. https://doi.org/10.1161/01.CIR.0000019743.11941.3B
- Yonetsu T, Kato K, Kim SJ, et al. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging 2012;5:660-6. https://doi.org/10.1161/CIRCIMAGING.112.976167
- Lee SY, Hur SH, Lee SG, et al. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation. Circ Cardiovasc Interv 2015;8:e001878.
- Otsuka F, Sakakura K, Yahagi K, et al. TCT-655 Contribution of in-stent neoatherosclerosis to late stent failure following bare metal and 1st- and 2nd-generation drug-eluting stent placement: an autopsy study. J Am Coll Cardiol 2014;64:B190-1.
- Mangiameli A, Ohno Y, Attizzani GF, Capodanno D, Tamburino C. Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold. JACC Cardiovasc Interv 2015;8:633-4. https://doi.org/10.1016/j.jcin.2014.11.014
- Hiltrop N, Jorge C, Bennett J, Adriaenssens T. Late neoatherosclerotic scaffold failure: an unexpected achilles heel for current bioresorbable scaffold technology? Int J Cardiol 2016;223:133-5. https://doi.org/10.1016/j.ijcard.2016.08.076
피인용 문헌
- Different Neointimal Pattern in Early vs. Late In-Stent Restenosis and Clinical Outcomes After Drug-Coated Balloon Angioplasty ― An Optical Coherence Tomography Study ― vol.82, pp.11, 2018, https://doi.org/10.1253/circj.cj-18-0619
- Restenosis of Drug-Eluting Stents : A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review vol.12, pp.8, 2017, https://doi.org/10.1161/circinterventions.118.007023
- Evaluation of a Targeted Drug‐Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model vol.1, pp.7, 2017, https://doi.org/10.1002/anbr.202000093
- Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes vol.18, pp.22, 2021, https://doi.org/10.3390/ijerph182211970
- Apport de la tomographie par cohérence optique dans la prise en charge de la resténose intrastent vol.70, pp.6, 2021, https://doi.org/10.1016/j.ancard.2021.10.010